Journal article icon

Journal article

Public health use of HIV phylogenetic data in sub-Saharan Africa: ethical issues

Abstract:
Phylogenetic analyses of HIV are an increasingly accurate method of clarifying population-level patterns of transmission and linking individuals or groups with transmission events. Viral genetic data may be used by public health agencies to guide policy interventions focused on clusters of transmission or segments of the population in which transmission is concentrated. Analyses of HIV phylogenetics in high-income countries have often found that clusters of transmission play a significant role in HIV epidemics. In sub-Saharan Africa, HIV phylogenetic analyses to date suggest that clusters of transmission play a relatively minor role in local epidemics. Such analyses could nevertheless be used to guide priority setting and HIV public health programme design in Africa for sub-populations in which transmission events are more concentrated. Phylogenetic analysis raises ethical issues, in part due to the range of potential benefits and potential harms (ie, risks). Potential benefits include (1) improving knowledge of transmission patterns, (2) informing the design of focused public health interventions for subpopulations in which transmission is concentrated, (3) identifying and responding to clusters of transmission, (4) reducing stigma (in some cases) and (5) informing estimates of the (cost-)effectiveness of HIV treatment programmes. Potential harms include (1) privacy infringements, (2) increasing stigma (in some cases), (3) reducing trust in public health programmes, and (4) increased prosecution of legal cases where HIV transmission, homosexuality or sex work is criminalised. This paper provides analysis of relevant issues with a focus on sub-Saharan Africa in order to inform consultations regarding ethical best practice for HIV phylogenetics
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1136/bmjgh-2023-011884

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-5940-602X
More by this author
Role:
Author
ORCID:
0000-0003-1498-3602
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-3662-4192
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-7054-4711


More from this funder
Funder identifier:
10.13039/100010269
Grant:
203132
More from this funder
Funder identifier:
10.13039/100000865
Grant:
INV-035619


Publisher:
BMJ Publishing Group
Journal:
BMJ Global Health More from this journal
Volume:
8
Issue:
7
Pages:
e011884-e011884
Publication date:
2023-07-05
Acceptance date:
2023-06-05
DOI:
EISSN:
2059-7908
ISSN:
2059-7908


Language:
English
Keywords:
Pubs id:
1491213
Local pid:
pubs:1491213
Source identifiers:
W4383197960
Deposit date:
2026-05-11
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP